Priority setting at the clinical level: the case of nusinersen and the Norwegian national expert group
Sign Up to like & getrecommendations! Published in 2021 at "BMC Medical Ethics"
DOI: 10.1186/s12910-021-00623-5
Abstract: Background Nusinersen is one of an increasing number of new, expensive orphan drugs to receive authorization. These drugs strain public healthcare budgets and challenge principles for resource allocation. Nusinersen was introduced in the Norwegian public… read more here.
Keywords: expert group; treatment; group; national expert ... See more keywords